Ozempic is a GLP-1 receptor agonist, while retatrutide is a triple-hormone receptor agonist, targeting GIP, GLP-1, and GCG simultaneously
Rather than following a rigid escalation schedule, this approach tailors the treatment to you
As a result, Lexaria is evaluating three of the most important GLP-1 agonist drugs in the market, semaglutide, liraglutide and tirzepatide
However, formulation studies often test several active ingredients together, making it difficult to attribute the result to one peptide.[2] A 2026 systematic review and meta-analysis of oral and topical peptides, covering 19 randomised controlled trials and 1,341 participants, found that peptides significantly improved skin hydration and brightness, with a modest pooled effect on wrinkle reduction (mean difference 0.27, p = 0.04)